2018 kicked off on a low note for generic drug approvals, but according to the latest activities report, the US Food and Drug Administration (FDA) in March began inching back to its fiscal year highs for approvals.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,